Argenx
ARGX
#421
Rank
C$82.27 B
Marketcap
C$1,308
Share price
3.63%
Change (1 day)
7.18%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2023 (TTM): C-$5.59

According to Argenx 's latest financial reports the company's current EPS (TTM) is C$31.55. In 2022 the company made an earnings per share (EPS) of C-$18.51.

EPS history for Argenx from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C-$5.59-69.81%
2022C-$18.51